APDN Applied DNA Sciences: Operatsion marja

adnas.com (APDN) kompaniyasining korporativ logotipi

PCR komponentlariga bo'lgan barqaror talab biznesni inflyatsiyadan himoya qilmoqda, biroq, GURU.Markets ning so'nggi grafigidagi joriy operatsion marja -406.10 darajasini ko'rsatmoqda, bu esa samaradorlikning pasayishidan dalolat beradi. Rahbariyatning DNK sintezi sohasidagi kompetentsiyasi va hisobotlar shaffofligi vaziyatni tuzatmoqda. Applied DNA Sciences (APDN) kompaniyasining benuqson imidji va yirik B2B hamkorlarining ishonchi uning molekulyar markirovka sohasidagi yetakchi maqomini tasdiqlaydi.

APDN: adnas.com Operatsion faoliyat rentabelligi 04.07.2022 - 07.10.2025

Applied DNA Sciences (APDN) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:adnas.com, APDN
Applied DNA Corp asosiy tovari

Operatsion marja moliyaviy xarajatlar va soliqlardan oldingi umumiy daromadga nisbatan asosiy biznes operatsiyalaridan olingan foyda ulushini aks ettirib, ichki xarajatlarni boshqarish samaradorligini ko'rsatadi. Haqiqiy operatsion marjaning tahlili Applied DNA Sciences (APDN) kompaniyasining arzon RFID yechimlari va AI tizimlari kengayishiga qarshi chidamliligini baholash imkonini beradi, bunda ushbu ko'rsatkichning o'sishi DNK markirovkasining muqobil variantlarga nisbatan raqobatbardosh ustunligini tasdiqlaydi.

Applied DNA Sciences raqobatchilari

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|SLN - Sotuvning operatsion rentabelligi|Operatsion marja PRQR (ProQR)|CDXS - Sotuvning operatsion marjasi|Sangamo Therapeutics Inc. - Operatsion marja|NAUT - Operatsion marja|MGX: Operatsion marja|Sotuvning operatsion marjasi Precision BioSciences, Inc.|GBIO (Generation Bio) - Operatsion marja|Boundless Bio Inc. (BOLD) - Operatsion faoliyat rentabelligi|Sotuvning operatsion marjasi XCUR (exicuretx.com)|Imunon Inc - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja PHIO (Phio Pharmaceuticals Corp)|Operatsion foyda normasi MBIO|RNAZ - Operatsion rentabellik|Operatsion foyda normasi BNGO (bionanogenomics.com)|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik